OP-145
£145.00 1mg
Antimicrobial peptide derived from LL-37.
OP-145 is a synthetic antimicrobial peptide derived from amino acid sequence 13 36 of human cathelicidin LL-37, further modified to favour the formation of an amphipathic helix. To improve stability against proteolytic degradation, the N-terminus is acetylated and the C-terminus amidated. OP-145 is a potent antibacterial, only lytic to human cells at high concentrations, and shows significant activity against nine methicillin-resistant Staphylococcus aureus (MRSA) strains, reducing their growth and biofilm formation. OP-145 is safe and effective against chronic middle ear infection (otitis media) in humans, and when formulated in poly(lactic-co-glycolic acid) (PLGA) microspheres, OP-145 exerts strong anti-biofilm effects on clinical isolated pathogens and exerts powerful anti-infection effects in vivo.
Please contact us for availability.
Additional information
Other Names | P60.4Ac |
---|---|
Three Letter Sequence | Ac-Ile-Gly-Lys-Glu-Phe-Lys-Arg-Ile-Val-Glu-Arg-Ile-Lys-Arg-Phe-Leu-Arg-Glu-Leu-Val-Arg-Pro-Leu-Arg-NH2 |
Molecular Weight | 3093.77 |
Molecular Formula | C142H246N46O31 |
Sequence | Ac-IGKEFKRIVERIKRFLRELVRPLR-NH2 |
Solubility | Soluble in water |
Appearance | Freeze dried solid |
Storage | Store dry, frozen and in the dark |
Purity | >95% by HPLC |
Modifications | N terminal acetyl, C terminal amide |
Searchable Words | OP 145, OP145, OP-145, Ac-IGKEFKRIVERIKRFLRELVRPLR-NH2, 732984-81-5, P60.4Ac |